Robert leads AIQ’s scientific strategy and research efforts, drawing on decades of work in medical physics and quantitative imaging to advance the company’s technology.

An internationally recognized researcher, his work focuses on tumor heterogeneity, treatment resistance, and the development of imaging-based methods that help clinicians better understand how patients respond to therapy. His research has helped shape the use of imaging biomarkers in clinical trials and contributed to the foundation of AIQ’s technology.

In addition to his role at AIQ, Dr. Jeraj is a Professor of Medical Physics and Human Oncology at the University of Wisconsin–Madison.

He received both his B.Sc. and Ph.D. in Physics from the University of Ljubljana in Slovenia.